Karl Cahill
Fundador en MOSS GENOMICS INC. .
Fortuna: 76 500 $ al 30/04/2024
Cargos activos de Karl Cahill
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOSS GENOMICS INC. | Director/Miembro de la Junta | 11/01/2021 | - |
| Director Ejecutivo | 11/01/2021 | - | |
| Fundador | 25/09/2018 | - |
Historial de carrera de Karl Cahill
Antiguos cargos conocidos de Karl Cahill.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Concordia Resource Corp.
 Concordia Resource Corp. Other Metals/MineralsNon-Energy Minerals Concordia Resource Corp. is a junior exploration company with an emphasis on developing mineral deposits in Africa and South America. The company has an extensive exploration portfolio in the resource-endowed regions of Burkina Faso, Gabon, and the Democratic Republic of Congo. In addition, it holds interests in the La Providencia silver mine located in the Puna district of northwestern Argentina and also holds interests in the Cerro Amarillo-Cajon Grande copper-gold-molybdenum property located in the Malargüe District of Argentina. The company was founded on February 7, 2000 and is headquartered in Vancouver, Canada. | Contacto de Relaciones con Inversores | 05/04/2011 | 16/08/2012 |
| Public Communications Contact | 25/08/2011 | 16/08/2012 | |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Public Communications Contact | 15/04/2009 | 01/10/2009 |
| ABRASILVER RESOURCE CORP. | Contacto de Relaciones con Inversores | - | - |
Formación de Karl Cahill.
| University of Westminster | Undergraduate Degree |
Estadísticas
Internacional
| Canadá | 4 |
| Estados Unidos | 2 |
| Reino Unido | 2 |
Operativa
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Non-Energy Minerals | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ABRASILVER RESOURCE CORP. | Non-Energy Minerals |
| MOSS GENOMICS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Concordia Resource Corp.
Concordia Resource Corp. Other Metals/MineralsNon-Energy Minerals Concordia Resource Corp. is a junior exploration company with an emphasis on developing mineral deposits in Africa and South America. The company has an extensive exploration portfolio in the resource-endowed regions of Burkina Faso, Gabon, and the Democratic Republic of Congo. In addition, it holds interests in the La Providencia silver mine located in the Puna district of northwestern Argentina and also holds interests in the Cerro Amarillo-Cajon Grande copper-gold-molybdenum property located in the Malargüe District of Argentina. The company was founded on February 7, 2000 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
- Bolsa de valores
- Insiders
- Karl Cahill
- Experiencia
